» glaxosmithkline » Hedge Fund News From HedgeCo.Net

Quick Hedge Fund Search | Advanced Hedge Fund Search

Each business day HedgeCo.Net keeps you informed with the top hedge fund industry news, opinion and insight from around the globe. From the latest hedge fund launches, to the impact of regulation, competition, and investor activism - we track the topics and people that make a difference to you.

Explore the most informative hedge fund articles and take the news with you, using HedgeCo's Hedge Fund News RSS

Still want more? Browse the hedge fund blogs, authored by hedge fund industry experts.

News Categories

By Topic:

By Date:

Today is Monday, March 22, 2010 at

- Countdown to Market Close:

Posts Tagged ‘glaxosmithkline’

Glaxo to buy Stiefel Labs for up to $3.6 billion

Monday, April 20, 2009 : Permalink

Reuters UK – GlaxoSmithKline Plc, the world’s second-largest drugmaker, has agreed to buy privately owned U.S. skincare specialist Stiefel Laboratories Inc for up to $3.6 billion, the two companies said on Monday.

The acquisition is the latest in a string of deals in the drugs sector, but is significantly smaller than recent mega-mergers, reflecting the British-based group’s declared focus on bolt-on buys to diversify its business.

Read Complete Article

Tags: acquisition, bolt, drugs, glaxosmithkline, glaxosmithkline plc, laboratories inc, mergers, reuters, skincare

trackback from your site.

JPMorgan tips drugmakers and non-life insurers

Wednesday, February 4, 2009 : Permalink

Reuters UK – JPMorgan Europe Dynamic fund favours defensive drugmakers and non-life insurers and has no plans to move into cyclicals until company newsflow, employment and money supply improve.

John Baker, portfolio manager of the 260 million euro (233.52 million pounds) fund, told Reuters his portfolio was invested in stocks with good newsflow and was mainly defensively positioned.

Baker favours GlaxoSmithKline which has taken a lot of cost out of its business and whose operating margins are improving, surprising the analyst community positively, he said.

Read Complete Article

Tags: analyst community, cyclicals, dynamic-fund, europe, glaxosmithkline, john baker, jpmorgan, life-insurers, money supply, operating margins, portfolio-manager, reuters, stocks

trackback from your site.

HedgeCo.Net

Glaxo to buy Stiefel Labs for up to $3.6 billion

JPMorgan tips drugmakers and non-life insurers

Investors

Hedge Fund Managers

My Account

Information / Support

Related Websites